Evogene Ltd stock is traded at $0.3634, with a volume of 19,924. It is down -8.09% in the last 24 hours and down -5.98% over the past month. Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
Previous Close:
$0.3954
Open:
$0.361
24h Volume:
19,924
Relative Volume:
0.02
Market Cap:
$4.94M
Revenue:
$1.84M
Net Income/Loss:
-$17.51M
P/E Ratio:
-
EPS:
-$1.38
Net Cash Flow:
-$17.30M
1W Performance:
+10.25%
1M Performance:
-5.98%
6M Performance:
-52.25%
1Y Performance:
-70.93%
1-Day Range:
$0.3569$0.3699
1-Week Range:
$0.2503$0.43
52-Week Range:
$0.2503$1.28
Evogene Ltd Stock (EVGN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS